Physician profile
Douglas E Roberts
NPI 1154367597
$14,698.06
in general payments reported to CMS, 2019-2025
67 companies · $2,255 in 2025
The $2,255 reported for 2025 was more than what 97% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,718 · 2020: $1,817 · 2021: $2,759 · 2022: $2,172 · 2023: $1,752 · 2024: $2,225 · 2025: $2,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,231.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,747.35 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,477.09 | 2019-2025 | Vraylar, Linzess, Ubrelvy |
| Novo Nordisk INC | $925.48 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $870.11 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $819.62 | 2019-2025 | Otezla, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $760.43 | 2022-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $635.51 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.93 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $564.73 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $496.40 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $488.85 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $472.74 | 2019-2025 | Spravato |
| Abbott Laboratories | $413.61 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $292.57 | 2019-2022 | |
| Dexcom, INC. | $245.64 | 2021-2025 | Dexcom G6 Transmitter |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $219.41 | 2019-2024 | Dificid |
| Corcept Therapeutics | $218.67 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $197.74 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $182.01 | 2019-2020 | |
| Esperion Therapeutics, INC. | $177.19 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.28 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $164.65 | 2021 | |
| Arbor Pharmaceuticals, INC. | $159.92 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $153.44 | 2020-2022 | |
| Smith+Nephew, INC. | $149.36 | 2019 | |
| Astellas Pharma US INC | $133.47 | 2019-2025 | Veozah |
| Boston Scientific Corporation | $132.10 | 2022-2024 | Spectra Wavewriter, Wavewriter Alpha Prime 16 |
| Axsome Therapeutics, INC. | $124.11 | 2022-2025 | Sunosi |
| Biohaven Pharmaceutical Holding Company LTD. | $123.30 | 2022 | |
| Pfizer INC. | $116.56 | 2020-2024 | |
| Upsher-Smith Laboratories LLC | $109.04 | 2019-2022 | |
| Antares Pharma, INC. | $98.60 | 2019-2025 | Xyosted |
| Eisai INC. | $96.02 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $91.05 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $89.93 | 2024-2025 | Zenpep |
| Glaxosmithkline, LLC. | $86.22 | 2020-2023 | Arexvy, Shingrix |
| Teva Pharmaceuticals USA, INC. | $80.51 | 2019-2021 | |
| Recor Medical INC | $69.37 | 2025 | Paradise Ultrasound Renal Denervation System |
| Inari Medical, INC. | $62.21 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Phathom Pharmaceuticals, INC. | $62.08 | 2024-2025 | Voquezna |
| Edwards Lifesciences Corporation | $44.77 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $44.30 | 2024 | Intellis Adaptivestim |
| Nestle Healthcare Nutrition INC. | $43.78 | 2021-2023 | |
| Irhythm Technologies, INC. | $43.74 | 2019 | |
| Sumitomo Pharma America, INC. | $37.83 | 2023-2025 | Gemtesa |
| Daiichi Sankyo INC. | $35.91 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $32.85 | 2020 | |
| Lundbeck LLC | $32.70 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $32.56 | 2020 | |
| Recordati_rare_diseases_inc. | $26.54 | 2025 | Isturisa |
| Noven Therapeutics, LLC | $24.04 | 2024 | Xelstrym |
| Stryker Corporation | $21.93 | 2025 | Clottriever Bold Catheter |
| Aytu Biopharma, INC. | $20.09 | 2019 | |
| Mannkind Corporation | $19.76 | 2021 | |
| Nevro Corp. | $17.93 | 2021 | |
| Teleflex LLC | $15.25 | 2024 | Urolift |
| Xeris Pharmaceuticals, INC. | $14.76 | 2023 | Gvoke Hypopen |
| Ironwood Pharmaceuticals, INC | $14.58 | 2019 | |
| Bausch Health US, LLC | $14.52 | 2022 | |
| Zyla Life Sciences, INC. | $14.31 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.29 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.98 | 2022 | |
| Cvrx, INC. | $13.45 | 2024 | Barostim Neo System |
| Insmed, INC. | $12.72 | 2022 | |
| Intersect Ent, INC. | $11.79 | 2019 | |
| Genentech USA, INC. | $11.69 | 2020 | |
| Gilead Sciences, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.